Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: A pathological study

American Journal of Gastroenterology

Volumn 92, Issue 4, 1997, Pages 586-591

  Cameron, Alan J ^a   Carpenter, Herschel A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0030933230     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Spechler SJ, Robbins AH, Rubins HB, et al. Adenocarcinoma and Barrett's esophagus: An overrated risk? Gastroenterology 1984;87: 927-33.
2. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
3. Hameeteman W, Tytgat GNJ, Houthoff HJ, et al. Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56.
4. Skinner DB, Walther BC, Riddell RH, et al. Barrett's esophagus: Comparison of benign and malignant cases. Ann Surg 1983;198:554-65.
5. Sanfey H, Hamilton SR, Smith RRL, et al. Carcinoma arising in Barrett's esophagus. Surg Gynecol Obstet 1985;161:570-4.
6. Menke-Pluymers MBE, Schoute NW, Mulder AH, et al. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 1992;33:1454-8.
7. Streitz JM, Ellis FH, Gibb SP, et al. Adenocarcinoma in Barrett's esophagus. A clinicopathological study of 65 cases. Ann Surg 1991; 213:122-5.
8. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315: 362-71.
9. Tytgat GNJ. Does endoscopic surveillance in esophageal columnar metaplasia have any real value? Endoscopy 1995;27:19-26.
10. Reid BJ, Blount PL, Rubin CE, et al. Flow cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort. Gastroenterology 1992;102:1212-9.
11. Palley SL, Sampliner RE, Garewal HS. Management of high-grade dysplasia in Barrett's esophagus. J Clin Gastroenterol 1989;11:369-72 (editorial).
12. Altorki NK, Sunagawa M, Little AG, et al. High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991;161:97-9.
13. Pera M, Trastek VT, Carpenter HA, et al. Barrett's esophagus with high-grade dysplasia. An indication for esophagectomy? Ann Thorac Surg 1992;54:199-204.
14. Cameron AJ, Lomboy CL, Pera M, et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-6.
15. Laukka MA, Wang KK. Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointest Endosc 1995;42:59-63.
16. Reid BJ, Weinstein WM, Lewin KJ, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988;94:81-90.
17. Rice TW, Falk GW, Achkar E, et al. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993;88: 1832-6.
18. Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105:40-50.
19. Robertson CS, Mayberry JF, Nicholson DA, et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988;75:760-3.
20. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 1991;32:1441-6.
21. Levine DS, Haggitt RC, Irvine S, et al. Natural history of high-grade dysplasia in Barrett's esophagus. Gastroenterology 1996;110:A550 (abstract).
22. Schnell T, Sontag SJ, Chejfec G, et al. High grade dysplasia (HGD) is not an indication for surgery in patients (Pts) with Barrett's esophagus (BE). Gastroenterology 1996;110:A590 (abstract).
23. Spechler SJ, Goyal RK. Cancer surveillance in Barrett's esophagus: What is the end point? Gastroenterology 1994;106:275-6 (letter).
24. Clark GWB, Ireland AP, DeMeester TR. Dysplastic Barrett's: Is continued surveillance appropriate? Gastroenterology 1994;106:1128 (letter).
25. McArdle JE, Lewin KJ, Randall G, et al. Distribtion of dysplasias and early invasive carcinoma in Barrett's esophagus. Hum Pathol 1992; 23:479-82.
26. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 1993;328:1237-43.
27. Takubo K, Sasajima K, Yamashita K, et al. Double muscularis mucosae in Barrett's esophagus. Hum Pathol 1991;22:1158-61.
28. Nishimaki T, Holscher AH, Schuler M, et al. Chronic esophagitis and subsequent morphological changes of the esophageal mucosa in Barrett's esophagus: A histological study of esophagectomy specimens. Surgery Today (Jpn J Surg) 1994;24:203-9.